Research
FORUM TRANSCRIPT

Bausch Health – Business Headwinds & 2022 Outlook

  • Credit
  • Healthcare
  • North America
PREMIUM

Specialist

Former senior executive at Bausch Health Companies Inc

Agenda

  • Key trends and developments in the generics pharmaceutical space
  • Bausch Health’s (NYSE: BHC) product pipeline and capabilities post spin-offs
  • Competitive positioning of major players surrounding Bausch Health, such as Johnson & Johnson (NYSE: JNJ) and Teva Pharmaceuticals (TLV: TEVA)
  • Cost reduction efforts and ability to generate free cash flow
  • 2022 outlook, turnaround potential and business risks

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo